Concentration of Asprosin Associated with Poor Control of Type 2 Diabetes Mellitus in Diyala Province

A newly secreted adipokine called asprosin is brought on by fasting as well as encourages hepatic glucose release. Its loss of function through immunologic or genetic methods has a significant effect on lowering glucose and insulin as a result of decreased hepatic glucose release. This study aimed...

Full description

Saved in:
Bibliographic Details
Main Authors: Alaa Abed Mahmoud, Walaa Ismael Jassim, Ahmed Abdul Hussein Mohsin, Ahmed M. Senan
Format: Article
Language:English
Published: middle technical university 2023-06-01
Series:Journal of Techniques
Subjects:
Online Access:https://journal.mtu.edu.iq/index.php/MTU/article/view/932
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832595139870064640
author Alaa Abed Mahmoud
Walaa Ismael Jassim
Ahmed Abdul Hussein Mohsin
Ahmed M. Senan
author_facet Alaa Abed Mahmoud
Walaa Ismael Jassim
Ahmed Abdul Hussein Mohsin
Ahmed M. Senan
author_sort Alaa Abed Mahmoud
collection DOAJ
description A newly secreted adipokine called asprosin is brought on by fasting as well as encourages hepatic glucose release. Its loss of function through immunologic or genetic methods has a significant effect on lowering glucose and insulin as a result of decreased hepatic glucose release. This study aimed to measure the level of asprosin in a group of poor control hyperglycemic patients and compare its level with the control group and find its correlation with obesity and lipid profile. Asprosin level in serum was assessed by enzyme-linked immunosorbent assay (ELISA) technique for 110 Iraqi patients with type 2 diabetes mellitus(T2DM), as well as 70 individual healthy controls. Percentage of glycated hemoglobin (HbAIc), fasting blood glucose (FBG), total cholesterol (TC), triglyceride (TG), high-density lipoprotein (HDL) and low-density lipoprotein (LDL) concentration were calculated using Roche cobas integra 400 plus. Patients with type 2 diabetes mellitus reported increased levels of asprosin in their blood when compared with controls (p < 0.001). A significant positive correlation was seen between asprosin and FBG in patient’s (P< 0.05). Non-significant correlation was seen between asprosin and body mass index (BMI) or lipid profile. In conclusion, according to the asprosin level in serum, there was a highly significant difference between patients with type 2 diabetes mellitus and control group. BMI and lipid abnormalities were not correlated to asprosin level in the serum of patients.
format Article
id doaj-art-ac44712e548945d399b171378b9a66e6
institution Kabale University
issn 1818-653X
2708-8383
language English
publishDate 2023-06-01
publisher middle technical university
record_format Article
series Journal of Techniques
spelling doaj-art-ac44712e548945d399b171378b9a66e62025-01-19T11:01:53Zengmiddle technical universityJournal of Techniques1818-653X2708-83832023-06-015210.51173/jt.v5i2.932Concentration of Asprosin Associated with Poor Control of Type 2 Diabetes Mellitus in Diyala ProvinceAlaa Abed Mahmoud0Walaa Ismael Jassim1Ahmed Abdul Hussein Mohsin2Ahmed M. Senan3College of Health & Medical Technology - Baghdad, Middle Technical University, Baghdad, IraqCollege of Health & Medical Technology - Baghdad, Middle Technical University, Baghdad, IraqVirginia Commonwealth University: Richmond, VA, USAFaculty of Pharmacy, Suleyman Demirel University, Isparta 32260, Türkiye A newly secreted adipokine called asprosin is brought on by fasting as well as encourages hepatic glucose release. Its loss of function through immunologic or genetic methods has a significant effect on lowering glucose and insulin as a result of decreased hepatic glucose release. This study aimed to measure the level of asprosin in a group of poor control hyperglycemic patients and compare its level with the control group and find its correlation with obesity and lipid profile. Asprosin level in serum was assessed by enzyme-linked immunosorbent assay (ELISA) technique for 110 Iraqi patients with type 2 diabetes mellitus(T2DM), as well as 70 individual healthy controls. Percentage of glycated hemoglobin (HbAIc), fasting blood glucose (FBG), total cholesterol (TC), triglyceride (TG), high-density lipoprotein (HDL) and low-density lipoprotein (LDL) concentration were calculated using Roche cobas integra 400 plus. Patients with type 2 diabetes mellitus reported increased levels of asprosin in their blood when compared with controls (p < 0.001). A significant positive correlation was seen between asprosin and FBG in patient’s (P< 0.05). Non-significant correlation was seen between asprosin and body mass index (BMI) or lipid profile. In conclusion, according to the asprosin level in serum, there was a highly significant difference between patients with type 2 diabetes mellitus and control group. BMI and lipid abnormalities were not correlated to asprosin level in the serum of patients. https://journal.mtu.edu.iq/index.php/MTU/article/view/932AsprosinPoor ControlType 2 Diabetes MellitusBMI
spellingShingle Alaa Abed Mahmoud
Walaa Ismael Jassim
Ahmed Abdul Hussein Mohsin
Ahmed M. Senan
Concentration of Asprosin Associated with Poor Control of Type 2 Diabetes Mellitus in Diyala Province
Journal of Techniques
Asprosin
Poor Control
Type 2 Diabetes Mellitus
BMI
title Concentration of Asprosin Associated with Poor Control of Type 2 Diabetes Mellitus in Diyala Province
title_full Concentration of Asprosin Associated with Poor Control of Type 2 Diabetes Mellitus in Diyala Province
title_fullStr Concentration of Asprosin Associated with Poor Control of Type 2 Diabetes Mellitus in Diyala Province
title_full_unstemmed Concentration of Asprosin Associated with Poor Control of Type 2 Diabetes Mellitus in Diyala Province
title_short Concentration of Asprosin Associated with Poor Control of Type 2 Diabetes Mellitus in Diyala Province
title_sort concentration of asprosin associated with poor control of type 2 diabetes mellitus in diyala province
topic Asprosin
Poor Control
Type 2 Diabetes Mellitus
BMI
url https://journal.mtu.edu.iq/index.php/MTU/article/view/932
work_keys_str_mv AT alaaabedmahmoud concentrationofasprosinassociatedwithpoorcontroloftype2diabetesmellitusindiyalaprovince
AT walaaismaeljassim concentrationofasprosinassociatedwithpoorcontroloftype2diabetesmellitusindiyalaprovince
AT ahmedabdulhusseinmohsin concentrationofasprosinassociatedwithpoorcontroloftype2diabetesmellitusindiyalaprovince
AT ahmedmsenan concentrationofasprosinassociatedwithpoorcontroloftype2diabetesmellitusindiyalaprovince